openPR Logo
Press release

Anti Epilepsy Drugs Market Overview 2018 Information by Pharmacological Class Diuretics, ACE Inhibitors, Calcium Channel Blockers, Adrenergic Blocker, etc. - Competitive Landscape and Forecasts to 2023

07-30-2018 01:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Anti Epilepsy Drugs Market

Anti Epilepsy Drugs Market

Market Research Future published a Cooked research report on “Global Anti-Epilepsy Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.

Global Anti-epilepsy Drugs Market - Overview

Epilepsy is a chronic disorder that causes unprovoked and recurrent seizures. Epilepsy is the fourth most common neurological disorder and affects people of all ages. The patients are reported to loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Increasing prevalence of the epilepsy, rising per capita healthcare expenditure and increasing R&D for the therapeutic procedures of the disease drives the market growth during the forecast period, 2017-2022.

Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/2345

According to the World Health Organization in 2017, approximately 50 million people across the globe have epilepsy, making it one of the most common neurological diseases globally. Moreover, it was estimated that nearly 80% of the people with epilepsy live in low- and middle-income countries.

The global anti-epilepsy drugs market is growing with the sound pace. According to a recent study report published by the Market Research Future, The global anti-epilepsy drugs market is booming and expected to gain prominence over the forecast period growing rapidly .The market is forecasted to demonstrate a sound growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).

Global anti-epilepsy drugs market - Key Players

Pfizer, Inc., Johnson & Johnson, UCB Pharma Ltd., Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Shire Pharmaceuticals Limited and Cephalon Inc.

Global Anti-epilepsy Drugs Market - Regional Analysis

On the regional backgrounds the Americas leads the global market for anti-epilepsy drugs owing to a well-developed healthcare sector, increasing prevalence of epilepsy and presence of the developed technologies within the region. According to the Centres for Disease Control and Prevention, in 2015, 1.2% of the total U.S. population had active epilepsy. Moreover, it was estimated that the yearly total direct and indirect cost of epilepsy in the U.S. was about USD 15.5 billion. Europe is second in the market due to rising healthcare expenditures, huge patient population and growing healthcare R&D expenses by the government. The Asia Pacific region is the fastest growing region due to the developing economies like India and China which are increasing their healthcare expenditures and have huge patient population. Moreover, favourable government policies within the region fuels the market growth. Middle East and Africa have the least market share, especially due to the presence of poor economies and stringent government policies within the African region.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/anti-epilepsy-drugs-market-2345

Global Anti-Epilepsy Drugs Market - Competitive Analysis

Characterized by the presence of several well-established and small players, the global anti-epilepsy drugs market appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Pfizer Inc. is one of the major players of the global anti-epilepsy drugs market and is headquartered in the U.S. In 2015, the company’s total revenue was about USD 48,851 million and it reached USD 52,824 million in 2016. Such a significant increase in the global sales, enabled the company to invest a huge percentage of their sales into the research and development. In 2016, the company spent 14.9% of its total revenue into the R&D enabling it to improve its product portfolio and launch new product, strengthening its position in the market.

In October 2016, Abbott has collaborated with Celgene and Agios for diagnostic identification of IDH mutations. Celgene has done an agreement with Abbott to develop and commercialize the diagnostic tests.

In November 2016, Novartis acquired Selexys Pharmaceuticals Corporation, a company specializing in development of therapeutics in certain hematologic and inflammatory disorders.

In August 2017, Sanofi completed the acquisition of Protein Sciences, a vaccines biotechnology company based in Meriden, Connecticut in the United States. This acquisition was followed by the Federal Trade Commission approval, having met all the conditions required for the closing of the transaction.

Table of Contents

1 Introduction

2 Research Methodology

3 Market Dynamics

4 Market Factor Analysis

5 Global Anti-Epilepsy Drugs Market, By Types Of Seizures

6 Global Anti-Epilepsy Drugs Market, By Generation

7 Global Anti-Epilepsy Drugs Market, By Regions

8 Company Landscape

9 Company Profile

10 Others

Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2345

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti Epilepsy Drugs Market Overview 2018 Information by Pharmacological Class Diuretics, ACE Inhibitors, Calcium Channel Blockers, Adrenergic Blocker, etc. - Competitive Landscape and Forecasts to 2023 here

News-ID: 1152654 • Views:

More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035. Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035. Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CAGR
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034. Cheese packaging
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by

All 5 Releases


More Releases for Anti

Black garlic might possess anti-cancer and anti-inflammatory benefits
The Wisconsin Fermentation Company is excited to announce groundbreaking research highlighting the significant health benefits of black garlic. Known for its unique flavor and texture, black garlic has long been valued in culinary traditions across the world. Recent studies now suggest that this fermented delicacy may possess potent anti-cancer and anti-inflammatory properties. Research Highlights Emerging research conducted by our team at the Wisconsin Fermentation Company, in collaboration with leading health experts, indicates that black garlic could be
Nanopharmaceuticals Market By Application ( Anti-infective, Anti-inflammatory, C …
Nanopharmaceuticals is an upcoming part of nanomedicine, which includes discovery/development and delivery of drugs using nanobiotechnology. It also includes the use of nanoparticles as therapeutic agents in various medical fields such as oncology, neurology, infectious diseases and others. nanopharmaceuticals are known to have different chemical, physical and biological properties as compared to their lager counterparts. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00003418/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: • Abbott • GlaxoSmithKline plc. • Stryker • Kadmon Holdings, Inc. •
Sleeplab Anti-Snore Reviews: Best Anti Snore Chin Strap?
if you and your partner share the same bed, snoring can be a bad habit. People who snore don't know how annoying it is to others who are around them. If you want to get rid of this, you need a gadget that can massage your throat and stop you from snoring at the same time. Almost half of adults snore while asleep. People who are overweight are more likely to
Anti-Venom Market Report 2018: Segmentation by Anti-Venom Type (Monovalent, Poly …
Global Anti-Venom market research report provides company profile for CSL Behring, Bharat Serums and Vaccines Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd, Vacsera, Vins Bioproducts Limited, Rare Therapeutics and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Anti-Suicide Drugs Market Report 2018: Segmentation by Chemistry Type (Anti-Depr …
Global Anti-Suicide Drugs market research report provides company profile for Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., Johnson & Johnson and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,
Top Leading Vendors of “Anti-Aging Products and Services Market” by product …
Axiom Market Research & Consulting added a latest report on ‘Global Anti-aging Products and Services Market, By Services, Devices, Products, Demographics, End Users and Geography – Global Market Share, Trend Analysis & Forecast Up To 2024’ The global anti-aging products and services market is anticipated to develop at a CAGR of 4.23% from 2019 to 2024. The market is revised for its services, such as anti-pigmentation therapy, adult acne therapy,